JUN and Alzheimer disease: These experiments complement those conducted in the FAD lines (including the isogenic pair) and unequivocally support that the pathological axis triggered by c-Jun dysregulation is a characteristic of AD, is conserved across AD types, and is not an artifact of the genetic and epigenetic heterogeneity of the different iPSC lines employed for this study.